The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study.


Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
May 2023
Historique:
received: 09 09 2022
accepted: 24 02 2023
medline: 8 5 2023
pubmed: 30 3 2023
entrez: 29 3 2023
Statut: ppublish

Résumé

Evidence linking body fatness to breast cancer (BC) prognosis is limited. While it seems that excess adiposity is associated with poorer BC survival, there is uncertainty over whether weight changes reduce mortality. This study aimed to assess the association between body fatness and weight changes pre- and postdiagnosis and overall mortality and BC-specific mortality among BC survivors. Our study included 13,624 BC survivors from the European Prospective Investigation into Cancer and Nutrition (EPIC) study, with a mean follow-up of 8.6 years after diagnosis. Anthropometric data were obtained at recruitment for all cases and at a second assessment during follow-up for a subsample. We measured general obesity using the body mass index (BMI), whereas waist circumference and A Body Shape Index were used as measures of abdominal obesity. The annual weight change was calculated for cases with two weight assessments. The association with overall mortality and BC-specific mortality were based on a multivariable Cox and Fine and Gray models, respectively. We performed Mendelian randomization (MR) analysis to investigate the potential causal association. Five-unit higher BMI prediagnosis was associated with a 10% (95% confidence interval: 5-15%) increase in overall mortality and 7% (0-15%) increase in dying from BC. Women with abdominal obesity demonstrated a 23% (11-37%) increase in overall mortality, independent of the association of BMI. Results related to weight change postdiagnosis suggested a U-shaped relationship with BC-specific mortality, with higher risk associated with losing weight or gaining > 2% of the weight annually. MR analyses were consistent with the identified associations. Our results support the detrimental association of excess body fatness on the survival of women with BC. Substantial weight changes postdiagnosis may be associated with poorer survival.

Identifiants

pubmed: 36988840
doi: 10.1007/s10654-023-00979-5
pii: 10.1007/s10654-023-00979-5
pmc: PMC10163997
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

545-557

Subventions

Organisme : AECC Scientific Foundation
ID : PRYES211366AGUD

Informations de copyright

© 2023. The Author(s).

Références

Ann Oncol. 2014 Oct;25(10):1901-1914
pubmed: 24769692
JAMA. 2021 Feb 16;325(7):686-687
pubmed: 33591334
J Clin Oncol. 2016 Dec 10;34(35):4203-4216
pubmed: 27903149
Cancers (Basel). 2019 Jul 27;11(8):
pubmed: 31357644
Ann Intern Med. 2017 May 02;166(9):613-620
pubmed: 28384755
BMC Med Res Methodol. 2012 Sep 24;12:148
pubmed: 23006680
Cancer Med. 2021 Aug;10(16):5614-5628
pubmed: 34196490
Am J Cardiol. 2018 Dec 15;122(12):2169-2171
pubmed: 30396509
J Clin Oncol. 2020 Apr 1;38(10):1081
pubmed: 32013670
JAMA Oncol. 2017 Mar 01;3(3):351-357
pubmed: 27832250
Breast Cancer Res. 2021 Feb 4;23(1):18
pubmed: 33541403
Nature. 2015 Feb 12;518(7538):197-206
pubmed: 25673413
Int J Cancer. 2023 Feb 15;152(4):572-599
pubmed: 36279884
Nat Rev Endocrinol. 2020 Mar;16(3):177-189
pubmed: 32020062
Bone Marrow Transplant. 2020 Mar;55(3):538-543
pubmed: 31101889
Public Health Nutr. 2002 Dec;5(6B):1147-62
pubmed: 12639224
Nat Rev Cancer. 2015 Aug;15(8):484-98
pubmed: 26205341
Breast Cancer Res Treat. 2010 Aug;122(3):823-33
pubmed: 20058068
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):44-50
pubmed: 27566419
Am J Clin Nutr. 2014 Jan;99(1):139-47
pubmed: 24225355
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
JAMA Netw Open. 2021 Mar 1;4(3):e213520
pubmed: 33779745
Sci Rep. 2020 Sep 3;10(1):14541
pubmed: 32883969
PLoS Genet. 2017 Oct 5;13(10):e1006944
pubmed: 28981501
Obesity (Silver Spring). 2018 Nov;26(11):1796-1806
pubmed: 30358150

Auteurs

Catalina Bonet (C)

Unit of Nutrition and Cancer, Epidemiology Research Program, Catalan Institute of Oncology-ICO, L'Hospitalet de Llobregat, Spain.
Nutrition and Cancer Group, Bellvitge Biomedical Research Institute-IDIBELL, Av. Granvia de L'Hospitalet 199-203, 08908, L'Hospitalet de Llobregat, Spain.

Marta Crous-Bou (M)

Unit of Nutrition and Cancer, Epidemiology Research Program, Catalan Institute of Oncology-ICO, L'Hospitalet de Llobregat, Spain.
Nutrition and Cancer Group, Bellvitge Biomedical Research Institute-IDIBELL, Av. Granvia de L'Hospitalet 199-203, 08908, L'Hospitalet de Llobregat, Spain.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.

Konstantinos K Tsilidis (KK)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

Marc J Gunter (MJ)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.

Renée T Fortner (RT)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of Researh, Cancer Registry of Norway, Oslo, Norway.

Christian S Antoniussen (CS)

Department of Public Health, Aarhus University, 8000, Aarhus C, Denmark.

Christina C Dahm (CC)

Department of Public Health, Aarhus University, 8000, Aarhus C, Denmark.

Lene Mellemkjær (L)

Danish Cancer Society Research Center, Diet, Genes and Environment, Copenhagen, Denmark.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Diet, Genes and Environment, Copenhagen, Denmark.

Pilar Amiano (P)

Sub Directorate for Public Health and Addictions of Gipuzkoa, Ministry of Health of the Basque Government, 2013, San Sebastian, Spain.
Epidemiology of Chronic and Communicable Diseases Group, Biodonostia Health Research Institute, 20014, San Sebastian, Spain.
CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Eva Ardanaz (E)

CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

Sandra M Colorado-Yohar (SM)

CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín, Colombia.

Miguel Rodriguez-Barranco (M)

CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Escuela Andaluza de Salud Pública (EASP), 18011, Granada, Spain.
Instituto de Investigación Biosanitaria Ibs.GRANADA, 18012, Granada, Spain.

Sandar Tin Tin (S)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Claudia Agnoli (C)

Epidemiology and Prevention Unit Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori Via Venezian, 1-20133, Milan, Italy.

Giovanna Masala (G)

Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Salvatore Panico (S)

Dipartimento Di Medicina Clinica E Chirurgia, Federico II University, Naples, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Via Santena 7, 10126, Turin, Italy.

Anne M May (AM)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Kristin Benjaminsen Borch (KB)

Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsö, Norway.

Charlotta Rylander (C)

Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsö, Norway.

Guri Skeie (G)

Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsö, Norway.

Sofia Christakoudi (S)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Department of Inflammation Biology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Dagfinn Aune (D)

Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
Department of Nutrition, Oslo New University College, Oslo, Norway.
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.

Elisabete Weiderpass (E)

Director Office, International Agency for Research on Cancer, World Health Organization, Lyon, France.

Laure Dossus (L)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Elio Riboli (E)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Epidemiology Research Program, Catalan Institute of Oncology-ICO, L'Hospitalet de Llobregat, Spain. a.agudo@iconcologia.net.
Nutrition and Cancer Group, Bellvitge Biomedical Research Institute-IDIBELL, Av. Granvia de L'Hospitalet 199-203, 08908, L'Hospitalet de Llobregat, Spain. a.agudo@iconcologia.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH